These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 6375926

  • 1. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD, Knudsen F, Nielsen AH, Ring T.
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [Abstract] [Full Text] [Related]

  • 2. Decreased sensitivity of platelets to prostacyclin in patients with diabetes mellitus.
    Akai T, Naka K, Okuda K, Takemura T, Fujii S.
    Horm Metab Res; 1983 Nov; 15(11):523-6. PubMed ID: 6360841
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction?
    Knudsen F, Kristensen SD, Nielsen AH, Ring T, Stoffersen E.
    Clin Nephrol; 1985 Feb; 23(2):107. PubMed ID: 3886225
    [No Abstract] [Full Text] [Related]

  • 7. Jogging causes a significant increase in platelet sensitivity to prostacyclin.
    Sinzinger H, Fitscha P.
    Int J Sports Med; 1986 Dec; 7(6):338-41. PubMed ID: 3542853
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Platelet activation during steady state sickle cell disease.
    Westwick J, Watson-Williams EJ, Krishnamurthi S, Marks G, Ellis V, Scully MF, White JM, Kakkar VV.
    J Med; 1983 Dec; 14(1):17-36. PubMed ID: 6224876
    [Abstract] [Full Text] [Related]

  • 11. The increased sensitivity of platelets to prostacyclin in marathon runners.
    Dix CJ, Hassall DG, Bruckdorfer KR.
    Thromb Haemost; 1984 Jul 29; 51(3):385-7. PubMed ID: 6093280
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB, Miller OV, Spillers C, Gorman RR.
    Prostaglandins; 1983 Aug 29; 26(2):287-302. PubMed ID: 6316420
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction.
    Jakubowski JA, Adler B, Thompson CB, Valeri CR, Deykin D.
    J Lab Clin Med; 1985 Feb 29; 105(2):271-6. PubMed ID: 3882862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.